New Zealand markets close in 3 hours 58 minutes

Identiv, Inc. (INVE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.3900-0.1000 (-2.23%)
At close: 04:00PM EDT
4.4600 +0.07 (+1.59%)
After hours: 05:16PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.4900
Open4.5050
Bid4.3800 x 100
Ask4.4400 x 200
Day's range4.3900 - 4.5050
52-week range4.0100 - 9.2600
Volume35,762
Avg. volume147,769
Market cap104.987M
Beta (5Y monthly)1.39
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Identiv Reports First Quarter 2024 Financial Results

    FREMONT, Calif., May 08, 2024--Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), today released its financial results for the first quarter ended March 31, 2024.

  • Business Wire

    Identiv Sets First Quarter 2024 Earnings Call for Wednesday, May 8, 2024 at 5:00 PM EDT

    FREMONT, Calif., April 26, 2024--Identiv, Inc. (NASDAQ: INVE), a global leader in digital security and identification in the Internet of Things (IoT), will hold a teleconference and webcast on Wednesday, May 8, 2024 at 5:00 PM EDT to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be published in a press release prior to the call and available in the investor relations section of the Company’s website.

  • Business Wire

    Identiv Welcomes Kirsten Newquist as President, IoT Solutions

    FREMONT, Calif., April 15, 2024--Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), today announced that Kirsten Newquist, a proven corporate leader with nearly 30 years’ experience in building successful businesses, has joined the company as President, IoT Solutions. Ms. Newquist will assume the role of CEO of Identiv upon closing of the company’s recently announced transaction with security solutions provider Vitaprotech.